Clinicopathological study on hepatitis C virus-associated glomerulonephritis without hepatitis C virus in the blood

Internal Medicine

Volumn 49, Issue 14, 2010, Pages 1321-1323

  Yamabe, Hideaki ^a,b   Nakamura, Norio ^a   Shimada, Michiko ^a   Murakami, Reiichi ^a   Fujita, Takeshi ^a   Shimaya, Yuko ^a   Kitajima, Maiko ^b   Urushizaka, Mayumi ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Cryoglobulin; HCV RNA; Hepatitis C; MPGN

Indexed keywords

CREATININE; RHEUMATOID FACTOR; VIRUS RNA;

ADULT; AGE; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HYPOCOMPLEMENTEMIA; KIDNEY INJURY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; NONHUMAN; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; GLOMERULONEPHRITIS; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL;

EID: 77955004546     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3596     Document Type: Article

References (10)

1. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328: 465-470, 1993.
2. Johnson RJ, Gretch DR, Couser WG, et al. Hepatitis C virusassociated glomerulonephritis. Effect of α-interferon therapy. Kidney Int 46: 1700-1704, 1994.
3. Yamabe H, Johnson RJ, Gretch DR, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon-alpha. Am J Kidney Dis 25: 67-69, 1995.
4. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronin non-A, non-B Hepatitis Study Team. N Engl J Med 327: 1899-1905, 1992.
5. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327: 1490-1495, 1992.
6. Misiani R, Bellavita P, Fenili D, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 117: 573-577, 1992.
7. Yamabe H, Nakamura N, Nakamura N, et al. Hepatitis C virusassociated glomerulonephritis without hepatitis C virus in the blood. Am J Kidney Dis 46: E65-E69, 2005.
8. Pimstone NR, Pimstone D, Saicbeur T, Powell J, Yu AS. "Waitand See": An alternative approach to managing acute hepatitis C with high-dose interferon-α monotherapy. Ann Intern Med 141: W91-W92, 2004.
9. Gerlach JT, Diepolder HM, Zachoval R, et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterol 125: 80-88, 2003.
10. Pham TN, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 78: 5867-5874, 2004.